LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease-Reference-Cited by-同舟云学术

LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease

Published:2023-10 Issue: Volume:882 Page:147639
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Usenko T.S.^ORCID,Senkevich K.A.,Basharova K.S.,Bezrukova A.I.,Baydakova G.V.^ORCID,Tyurin A.A.^ORCID,Beletskaya M.V.^ORCID,Kulabukhova D.G.^ORCID,Grunina M.N.,Emelyanov A.K.,Miliukhina I.V.,Timofeeva A.A.,Zakharova E.Y.,Pchelina S.N.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference66 articles.

1. Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations;Alcalay;Brain,2015

2. Alpha galactosidase A activity in Parkinson’s disease;Alcalay;Neurobiol Dis,2018

3. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson’s disease;Alcalay;Movement Disorders,2019

4. Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients;Bardien;Mov Disord,2013

5. Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease;Chang;Cells,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Dependent Alterations of Lysosomal Activity and Alpha-Synuclein in Peripheral Blood Monocyte-Derived Macrophages and SH-SY5Y Neuroblastoma Cell Line by upon Inhibition of MTOR Protein Kinase – Assessment of the Prospects of Parkinson’s Disease Therapy;Biochemistry (Moscow);2024-07

2. The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene;Journal of Integrative Neuroscience;2024-01-16

3. Emerging Role of Astrocyte-Derived Extracellular Vesicles as Active Participants in CNS Neuroimmune Responses;Immunological Investigations;2023-11-19